Back
Blueprint Medicines Stock Predictions

Slow Market? Try This Instead
See how it works now.
Sell
50
BPMC
Blueprint Medicines
Last Price:
$128.39
Seasonality Move:
6.28%
7 Day Trial
ALL ACCESS PASS
$
7

Your Summer Trading Shortcut
Try it free today.Blueprint Medicines Stock Forecast
-
Over the next 52 weeks, Blueprint Medicines has on average historically risen by 26.4% based on the past 10 years of stock performance.
-
Blueprint Medicines has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
-
Is Blueprint Medicines Stock Undervalued?The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Blueprint Medicines Stock Go Up Next Year?
-
Over the next 52 weeks, Blueprint Medicines has on average historically risen by 26.4% based on the past 10 years of stock performance.
Blueprint Medicines Stock Rating
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines overpriced?
-
Blueprint Medicines has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Blueprint Medicines Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com
52-Week Data
52-Week High:
128.52
52-Week Low:
73.04
Prediction Charts
Market Cap:
8.3B
Price in USD:
128.35
Volume:
1.4M
Beta:
0.99
Technical Analysis
SMA50:
111.57
SMA100:
100.78
SMA200:
97.60
52-Wk Change:
17.72%
Stock Predictions
-
Is Blueprint Medicines stock public?Yes, Blueprint Medicines is a publicly traded company.
-
What is the Blueprint Medicines stock quote today?The Blueprint Medicines stock price is 128.35 USD today.
-
How to buy Blueprint Medicines stock online?You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-13 | 128.18 | 127.96 | 128.27 | 127.95 |
Jun-16 | 128.05 | 128.25 | 128.30 | 127.86 |
Jun-17 | 128.14 | 128.23 | 128.33 | 128.03 |
Jun-18 | 128.29 | 128.12 | 128.32 | 128.02 |
Jun-20 | 128.27 | 128.20 | 128.30 | 128.00 |
Jun-23 | 128.19 | 128.40 | 128.45 | 128.11 |
Jun-24 | 128.40 | 128.26 | 128.40 | 128.15 |
Jun-25 | 128.30 | 128.25 | 128.32 | 128.19 |
Jun-26 | 128.29 | 128.15 | 128.31 | 128.10 |
Jun-27 | 128.24 | 128.11 | 128.28 | 128.06 |
Jun-30 | 128.30 | 128.18 | 128.32 | 128.08 |
Jul-1 | 128.18 | 128.34 | 128.52 | 128.16 |
Jul-2 | 128.35 | 128.20 | 128.45 | 128.20 |
Jul-3 | 128.25 | 128.35 | 128.40 | 128.20 |
Blueprint Medicines Earnings
Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.
Blueprint Medicines Forecast Revenue Growth
Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.